Quantitative proteomic analysis of human breast epithelial cells with differential telomere length

Biochemical and Biophysical Research Communications

Volumn 356, Issue 4, 2007, Pages 942-947

  Yu, Li Rong ^a   Chan, King C ^a   Tahara, Hidetoshi ^b   Lucas, David A ^a   Chatterjee, Koushik ^a   Issaq, Haleem J ^a   Veenstra, Timothy D ^a  

^a SAIC FREDERICK INC   (United States)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Breast epithelial cells; ICAT; Mass spectrometry; Quantitative proteomics; Telomere length

Indexed keywords

AMINO ACID; CELL DNA; INTEGRIN; ISOTOPE; LIGAND; LIPID; NUCLEOTIDE; PROTEIN; TELOMERASE REVERSE TRANSCRIPTASE;

AMINO ACID METABOLISM; ARTICLE; BREAST EPITHELIUM; CELL FUNCTION; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; EXCISION REPAIR; GENE CONTROL; GENE FUNCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIPID METABOLISM; NUCLEOTIDE METABOLISM; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; QUANTITATIVE ANALYSIS; RIBOSOME; SIGNAL TRANSDUCTION; SPLICEOSOME; TELOMERE; TRANSCRIPTION REGULATION; TRANSLATION REGULATION;

BREAST; CELL LINE; DNA REPAIR; EPITHELIAL CELLS; HUMANS; PROTEOME; TELOMERE;

EID: 34047120210     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.03.069     Document Type: Article

References (26)

1. Azzalin C.M., and Lingner J. Telomere wedding ends in divorce. Science 304 (2004) 60-62
2. Hackett J.A., Feldser D.M., and Greider C.W. Telomere dysfunction increases mutation rate and genomic instability. Cell 106 (2001) 275-286
3. Reddel R.R. Alternative lengthening of telomeres, telomerase, and cancer. Cancer Lett. 194 (2003) 155-162
4. Wang J.C., Warner J.K., Erdmann N., Lansdorp P.M., Harrington L., and Dick J.E. Dissociation of telomerase activity and telomere length maintenance in primitive human hematopoietic cells. Proc. Natl. Acad. Sci. USA 102 (2005) 14398-14403
5. Hao L.Y., Armanios M., Strong M.A., Karim B., Feldser D.M., Huso D., and Greider C.W. Short telomeres, even in the presence of telomerase, limit tissue renewal capacity. Cell 123 (2005) 1121-1131
6. Hemann M.T., Strong M.A., Hao L.Y., and Greider C.W. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 107 (2001) 67-77
7. Lindvall C., Hou M., Komurasaki T., Zheng C., Henriksson M., Sedivy J.M., Bjorkholm M., Teh B.T., Nordenskjold M., and Xu D. Molecular characterization of human telomerase reverse transcriptase-immortalized human fibroblasts by gene expression profiling: activation of the epiregulin gene. Cancer Res. 63 (2003) 1743-1747
8. Armstrong L., Saretzki G., Peters H., Wappler I., Evans J., Hole N., von Zglinicki T., and Lako M. Overexpression of telomerase confers growth advantage, stress resistance, and enhanced differentiation of ESCs toward the hematopoietic lineage. Stem Cells 23 (2005) 516-529
9. Askree S.H., Yehuda T., Smolikov S., Gurevich R., Hawk J., Coker C., Krauskopf A., Kupiec M., and McEachern M.J. A genome-wide screen for Saccharomyces cerevisiae deletion mutants that affect telomere length. Proc. Natl. Acad. Sci. USA 101 (2004) 8658-8663
10. Gygi S.P., Rist B., Gerber S.A., Turecek F., Gelb M.H., and Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 17 (1999) 994-999
11. Washburn M.P., Wolters D., and Yates III J.R. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 19 (2001) 242-247
12. Yu L.R., Conrads T.P., Uo T., Issaq H.J., Morrison R.S., and Veenstra T.D. Evaluation of the acid-cleavable isotope-coded affinity tag reagents: application to camptothecin-treated cortical neurons. J. Proteome Res. 3 (2004) 469-477
13. Annab L.A., Terry L., Cable P.L., Brady J., Stampfer M.R., Barrett J.C., and Afshari C.A. Establishment and characterization of a breast cell strain containing a BRCA1 185delAG mutation. Gynecol. Oncol. 77 (2000) 121-128
14. Nakayama J., Tahara H., Tahara E., Saito M., Ito K., Nakamura H., Nakanishi T., Tahara E., Ide T., and Ishikawa F. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat. Genet. 18 (1998) 65-68
15. Stampfer M.R., Garbe J., Levine G., Lichtsteiner S., Vasserot A.P., and Yaswen P. Expression of the telomerase catalytic subunit, hTERT, induces resistance to transforming growth factor beta growth inhibition in p16INK4A(-) human mammary epithelial cells. Proc. Natl. Acad. Sci. USA 98 (2001) 4498-4503
16. Brenner A.J., Stampfer M.R., and Aldaz C.M. Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation. Oncogene 17 (1998) 199-205
17. Yu L.R., Conrads T.P., Uo T., Kinoshita Y., Morrison R.S., Lucas D.A., Chan K.C., Blonder J., Issaq H.J., and Veenstra T.D. Global analysis of the cortical neuron proteome. Mol. Cell. Proteomics 3 (2004) 896-907
18. Sharma G.G., Gupta A., Wang H., Scherthan H., Dhar S., Gandhi V., Iliakis G., Shay J.W., Young C.S., and Pandita T.K. hTERT associates with human telomeres and enhances genomic stability and DNA repair. Oncogene 22 (2003) 131-146
19. Shin J.S., Hong A., Solomon M.J., and Soon Lee C. The role of telomeres and telomerase in the pathology of human cancer and aging. Pathology 38 (2006) 103-113
20. Shin K.H., Kang M.K., Dicterow E., Kameta A., Baluda M.A., and Park N.H. Introduction of human telomerase reverse transcriptase to normal human fibroblasts enhances DNA repair capacity. Clin. Cancer Res. 10 (2004) 2551-2560
21. Tanaka H., Mendonca M.S., Bradshaw P.S., Hoelz D.J., Malkas L.H., Meyn M.S., and Gilley D. DNA damage-induced phosphorylation of the human telomere-associated protein TRF2. Proc. Natl. Acad. Sci. USA 102 (2005) 15539-15544
22. Bradshaw P.S., Stavropoulos D.J., and Meyn M.S. Human telomeric protein TRF2 associates with genomic double-strand breaks as an early response to DNA damage. Nat. Genet. 37 (2005) 193-197
23. Drees B.E., Andrews K.M., and Beckerle M.C. Molecular dissection of zyxin function reveals its involvement in cell motility. J. Cell Biol. 147 (1999) 1549-1560
24. Dourdin N., Bhatt A.K., Dutt P., Greer P.A., Arthur J.S., Elce J.S., and Huttenlocher A. Reduced cell migration and disruption of the actin cytoskeleton in calpain-deficient embryonic fibroblasts. J. Biol. Chem. 276 (2001) 48382-48388
25. Franco S., Canela A., Klatt P., and Blasco M.A. Effectors of mammalian telomere dysfunction: a comparative transcriptome analysis using mouse models. Carcinogenesis 26 (2005) 1613-1626
26. Mondello C., Petropoulou C., Monti D., Gonos E.S., Franceschi C., and Nuzzo F. Telomere length in fibroblasts and blood cells from healthy centenarians. Exp. Cell Res. 248 (1999) 234-242